Although much more research is needed to understand the full benefit of targeting ion channels as an anticancer therapy, we propose that stimulation of the activity of K+ channels such as Kv11.1 could be considered as a potential approach to design a novel anti-breast cancer therapy. This evidence concerns the gene KCNH2 and breast carcinoma.